194 related articles for article (PubMed ID: 33017604)
1. ADC measurements on the Unity MR-linac - A recommendation on behalf of the Elekta Unity MR-linac consortium.
Kooreman ES; van Houdt PJ; Keesman R; Pos FJ; van Pelt VWJ; Nowee ME; Wetscherek A; Tijssen RHN; Philippens MEP; Thorwarth D; Wang J; Shukla-Dave A; Hall WA; Paulson ES; van der Heide UA
Radiother Oncol; 2020 Dec; 153():106-113. PubMed ID: 33017604
[TBL] [Abstract][Full Text] [Related]
2. Accuracy and precision of apparent diffusion coefficient measurements on a 1.5 T MR-Linac in central nervous system tumour patients.
Lawrence LSP; Chan RW; Chen H; Keller B; Stewart J; Ruschin M; Chugh B; Campbell M; Theriault A; Stanisz GJ; MacKenzie S; Myrehaug S; Detsky J; Maralani PJ; Tseng CL; Czarnota GJ; Sahgal A; Lau AZ
Radiother Oncol; 2021 Nov; 164():155-162. PubMed ID: 34592363
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of diffusion-weighted MRI and geometric distortion on a 0.35T MR-LINAC at multiple gantry angles.
Lewis B; Guta A; Mackey S; Gach HM; Mutic S; Green O; Kim T
J Appl Clin Med Phys; 2021 Feb; 22(2):118-125. PubMed ID: 33450146
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal assessment of quality assurance measurements in a 1.5 T MR-linac: Part II-Magnetic resonance imaging.
Subashi E; Dresner A; Tyagi N
J Appl Clin Med Phys; 2022 Jun; 23(6):e13586. PubMed ID: 35332990
[TBL] [Abstract][Full Text] [Related]
5. Repeatability quantification of brain diffusion-weighted imaging for future clinical implementation at a low-field MR-linac.
Rabe M; Dietrich O; Forbrig R; Niyazi M; Belka C; Corradini S; Landry G; Kurz C
Radiat Oncol; 2024 Mar; 19(1):31. PubMed ID: 38448888
[TBL] [Abstract][Full Text] [Related]
6. Prostate diffusion-weighted imaging (DWI) in MR-guided radiotherapy: Reproducibility assessment on 1.5 T MR-Linac and 1.5 T MR-simulator.
Wong OL; Yuan J; Poon DMC; Chiu ST; Yang B; Chiu G; Yu SK; Cheung KY
Magn Reson Imaging; 2024 Mar; 111():47-56. PubMed ID: 38513789
[TBL] [Abstract][Full Text] [Related]
7. Validation of echo planar imaging based diffusion-weighted magnetic resonance imaging on a 0.35 T MR-Linac.
Wallimann P; Piccirelli M; Nowakowska S; Armstrong T; Mayinger M; Boss A; Bink A; Guckenberger M; Tanadini-Lang S; Andratschke N; Pouymayou B
Phys Imaging Radiat Oncol; 2024 Apr; 30():100579. PubMed ID: 38707628
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study.
Almansour H; Schick F; Nachbar M; Afat S; Fritz V; Thorwarth D; Zips D; Bertram F; Müller AC; Nikolaou K; Othman AE; Wegener D
Radiol Oncol; 2023 Jun; 57(2):184-190. PubMed ID: 37341194
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers.
McDonald BA; Salzillo T; Mulder S; Ahmed S; Dresner A; Preston K; He R; Christodouleas J; Mohamed ASR; Philippens M; van Houdt P; Thorwarth D; Wang J; Shukla Dave A; Boss M; Fuller CD
Radiother Oncol; 2023 Aug; 185():109717. PubMed ID: 37211282
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and accuracy of quantitative imaging on a 1.5 T MR-linear accelerator.
Kooreman ES; van Houdt PJ; Nowee ME; van Pelt VWJ; Tijssen RHN; Paulson ES; Gurney-Champion OJ; Wang J; Koetsveld F; van Buuren LD; Ter Beek LC; van der Heide UA
Radiother Oncol; 2019 Apr; 133():156-162. PubMed ID: 30935572
[TBL] [Abstract][Full Text] [Related]
11. MRI B
Jackson S; Glitzner M; Tijssen RHN; Raaymakers BW
Phys Med Biol; 2019 Jun; 64(12):12NT01. PubMed ID: 31108467
[TBL] [Abstract][Full Text] [Related]
12. Validation of daily 0.35 T diffusion-weighted MRI for MRI-guided glioblastoma radiotherapy.
Lutsik N; Nejad-Davarani SP; Valderrama A; Herr J; Maziero D; Cullison K; Azzam GA; Kubicek GJ; Meshman J; de la Fuente MI; Armstrong T; Mellon EA
Med Phys; 2024 Apr; ():. PubMed ID: 38588475
[TBL] [Abstract][Full Text] [Related]
13. Tuning the optimal diffusion-weighted MRI parameters on a 0.35-T MR-Linac for clinical implementation: A phantom study.
Nardini M; Capotosti A; Mazzoni LN; Cusumano D; Boldrini L; Chiloiro G; Romano A; Valentini V; Indovina L; Placidi L
Front Oncol; 2022; 12():867792. PubMed ID: 36523999
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for improved reproducibility of ADC derivation on behalf of the Elekta MRI-linac consortium image analysis working group.
Bisgaard ALH; Keesman R; van Lier ALHMW; Coolens C; van Houdt PJ; Tree A; Wetscherek A; Romesser PB; Tyagi N; Lo Russo M; Habrich J; Vesprini D; Lau AZ; Mook S; Chung P; Kerkmeijer LGW; Gouw ZAR; Lorenzen EL; van der Heide UA; Schytte T; Brink C; Mahmood F
Radiother Oncol; 2023 Sep; 186():109803. PubMed ID: 37437609
[TBL] [Abstract][Full Text] [Related]
15. Impact of measurement parameters on apparent diffusion coefficient quantification in diffusion-weighted-magnetic resonance imaging.
Schmidt H; Gatidis S; Schwenzer NF; Martirosian P
Invest Radiol; 2015 Jan; 50(1):46-56. PubMed ID: 25247326
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of diffusion weighted imaging in rectal cancer during radiotherapy using a magnetic resonance imaging integrated linear accelerator.
Ingle M; Blackledge M; White I; Wetscherek A; Lalondrelle S; Hafeez S; Bhide S
Phys Imaging Radiat Oncol; 2022 Jul; 23():32-37. PubMed ID: 35756883
[TBL] [Abstract][Full Text] [Related]
17. Improved accuracy of apparent diffusion coefficient quantification using a fully automatic noise bias compensation method: Preliminary evaluation in prostate diffusion weighted imaging.
Zhong X; Dale BM; Nickel MD; Kannengiesser SAR; Kiefer B; Bashir M
J Magn Reson; 2019 Aug; 305():22-30. PubMed ID: 31158792
[TBL] [Abstract][Full Text] [Related]
18. Quality assurance multicenter comparison of different MR scanners for quantitative diffusion-weighted imaging.
Belli G; Busoni S; Ciccarone A; Coniglio A; Esposito M; Giannelli M; Mazzoni LN; Nocetti L; Sghedoni R; Tarducci R; Zatelli G; Anoja RA; Belmonte G; Bertolino N; Betti M; Biagini C; Ciarmatori A; Cretti F; Fabbri E; Fedeli L; Filice S; Fulcheri CP; Gasperi C; Mangili PA; Mazzocchi S; Meliadò G; Morzenti S; Noferini L; Oberhofer N; Orsingher L; Paruccini N; Princigalli G; Quattrocchi M; Rinaldi A; Scelfo D; Freixas GV; Tenori L; Zucca I; Luchinat C; Gori C; Gobbi G;
J Magn Reson Imaging; 2016 Jan; 43(1):213-9. PubMed ID: 26013043
[TBL] [Abstract][Full Text] [Related]
19. Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI.
Almansour H; Afat S; Fritz V; Schick F; Nachbar M; Thorwarth D; Zips D; Müller AC; Nikolaou K; Othman AE; Wegener D
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810410
[TBL] [Abstract][Full Text] [Related]
20. Two-dimensional EPID dosimetry for an MR-linac: Proof of concept.
Torres-Xirau I; Olaciregui-Ruiz I; van der Heide UA; Mans A
Med Phys; 2019 Sep; 46(9):4193-4203. PubMed ID: 31199521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
